Mental health issues are a silent epidemic. Drug and alcohol addiction afflicts one in ten Americans. Major depressive disorder and anxiety disorder impact 6–7% of the U.S. population.
Emotional health involves complex interactions between an individual’s neurogenetic chemistry and the environment. Contributing factors include neurotransmitter imbalances, mood disorders, inflammation, exaggerated stress response, response to trauma, cognitive flexibility, and inadequate sleep. Genoma International has developed specific testing that evaluates genes in all of these areas, providing a personalized guide to strategic prevention and treatment.
Our Cognitive-Emotional Health and Ultimate Wellness genomic test panels evaluate many areas affecting emotional health including:
Depression, Anxiety, Addiction, Emotional Eating, Neuropeptides, Neuroplasticity, Neurotransmitters, Micronutrients, Methylation, Oxidative Stress, Inflammation, Traumatic Brain Injury.
Pharmacogenomic testing can help you guide your patients to the right medications when diet, lifestyle and therapy are not enough.